Daito Pharmaceutical Co (TSE:4577) Shares Outstanding (EOP): 29 Mil (As of Nov. 2025)


TSE:4577 Daito Pharmaceutical Co Ltd TSE:4577
78 GF Score
Price 円1,246.00
GF Value 円1,278.73
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Daito Pharmaceutical Co Shares Outstanding (EOP)?

Daito Pharmaceutical Co TSE:4577 +0.40% 78 Shares Outstanding (EOP) is 29 Mil as of Nov. 2025. GuruFocus rates TSE:4577 with a GF Score™ of 78/100 and a GF Value™ of 円1,278.73 (Fairly Valued). The stock has 3 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Daito Pharmaceutical Co's shares outstanding for the quarter that ended in Nov. 2025 was 29 Mil.

Daito Pharmaceutical Co's quarterly shares outstanding declined from Aug. 2025 (30 Mil) to Nov. 2025 (29 Mil). It means Daito Pharmaceutical Co bought back shares from Aug. 2025 to Nov. 2025 .

Daito Pharmaceutical Co's annual shares outstanding declined from May. 2024 (31 Mil) to May. 2025 (30 Mil). It means Daito Pharmaceutical Co bought back shares from May. 2024 to May. 2025 .


Daito Pharmaceutical Co  (TSE:4577) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Daito Pharmaceutical Co Shares Outstanding (EOP) Related Terms


Daito Pharmaceutical Co Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Daito Pharmaceutical Co's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daito Pharmaceutical Co Shares Outstanding (EOP) Chart

Daito Pharmaceutical Co Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.17 31.43 31.70 30.59 29.99

Daito Pharmaceutical Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.29 29.99 29.61 29.49 29.16

TSE:4577 vs ZTS, UTHR: Shares Outstanding (EOP) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Daito Pharmaceutical Co's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daito Pharmaceutical Co Shares Outstanding (EOP) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daito Pharmaceutical Co's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Daito Pharmaceutical Co's Shares Outstanding (EOP) falls into.


TSE:4577
78GF Score
Daito Pharmaceutical Co Ltd TSE:4577
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daito Pharmaceutical Co Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 29 Mil mean?
Daito Pharmaceutical Co (TSE:4577) has a Shares Outstanding (EOP) of 29 Mil as of Nov. 2025. The total shares a company has outstanding, at period-end. View historical data on Daito Pharmaceutical Co and its competitors.
Is Daito Pharmaceutical Co's Shares Outstanding (EOP) too high?
Daito Pharmaceutical Co's current Shares Outstanding (EOP) is 29 Mil. Overall, Daito Pharmaceutical Co has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Daito Pharmaceutical Co's Shares Outstanding (EOP) compare to ZTS and UTHR?
Daito Pharmaceutical Co's Shares Outstanding (EOP) of 29 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Drug Manufacturers company?
A good Shares Outstanding (EOP) depends on the Drug Manufacturers industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Daito Pharmaceutical Co and its competitors. Daito Pharmaceutical Co's current Shares Outstanding (EOP) is 29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daito Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Daito Pharmaceutical Co (TSE:4577) is currently considered Fairly Valued. The stock's GF Value™ is 円1,278.73, compared to a current price of 円1,246.00 — trading 2.6% below its estimated fair value. The current Shares Outstanding (EOP) is 29 Mil. Daito Pharmaceutical Co's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Daito Pharmaceutical Co (TSE:4577), the current Shares Outstanding (EOP) is 29 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daito Pharmaceutical Co (TSE:4577) Overvalued in 2026?

Based on GuruFocus' analysis, Daito Pharmaceutical Co stock appears to be undervalued. The current stock price of 円1,246.00 is trading 2.6% below its estimated GF Value™ of 円1,278.73. GuruFocus considers Daito Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TSE:4577:

  • Shares Outstanding (EOP): 29 Mil
  • GF Value™: 円1,278.73 vs. price of 円1,246.00 (2.6% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the TSE:4577 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Daito Pharmaceutical Co Business Description

Address 326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.
78GF Score

Get the complete analysis for TSE:4577

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,246.00
Price
円1,278.73
GF Value